Qdata® by Verana Health are research ready, fit-for-purpose data modules designed to confidently drive business insights and inform research outcomes. Qdata spans ophthalmology, neurology, and urology to help unlock quality insights across the entire drug and device development cycle.
Exclusive Insights into Anti-VEGF Usage
Only found here from the IRIS® Registry (Intelligent Research in Sight)
Accurate and Timely Data
Regularly refreshed data from the same clinical sources with a ~3 week data lag
Granular Market Segmentation Down to the Brand Level
Curated EHR data can be segmented by brand, geography, demographics and more
By the Numbers: 2022
Total de-identified patients who received anti-VEGF injections*
Number of anti-VEGF injections
*Data as of September 2023. Data counts represented are subject to change. Data counts for research purposes are dependent on project scope, feasibility and integration status.
Meet with a Qdata Expert or Request a Data Count
View Market Dashboards
Qdata Anti-VEGF Market Tracker delivers insights into market dynamics in intuitive, self service dashboards for day-to-day use.
- Track rolling market share and KPIs of interest
- Monitor real-world usage of your drug, including brand switching or brand usage by indication
- Data refreshed monthly with a ~3 week data lag
Leverage our flexible dashboards to track your KPIs or access the data directly on demand via SFTP or AWS Data Exchange.
Read More About Qdata Anti-VEGF
Check out research, blogs and news related to Qdata Anti-VEGF Market Tracker.
Talk to a Qdata Expert
Take a minute to submit your contact information and one of our team members will reach out to you.